CN116987043A - Atmospheric catalytic CO 2 Method for synthesizing oxazolidinone compound - Google Patents
Atmospheric catalytic CO 2 Method for synthesizing oxazolidinone compound Download PDFInfo
- Publication number
- CN116987043A CN116987043A CN202310964404.1A CN202310964404A CN116987043A CN 116987043 A CN116987043 A CN 116987043A CN 202310964404 A CN202310964404 A CN 202310964404A CN 116987043 A CN116987043 A CN 116987043A
- Authority
- CN
- China
- Prior art keywords
- catalytic
- synthesizing
- reaction
- acac
- oxazolidinone compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 28
- 230000003197 catalytic effect Effects 0.000 title claims abstract description 27
- -1 oxazolidinone compound Chemical class 0.000 title claims abstract description 22
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 63
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 claims abstract description 40
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 claims abstract description 24
- 150000001541 aziridines Chemical class 0.000 claims abstract description 7
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 4
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical group [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 claims description 32
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 10
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Natural products CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 238000003786 synthesis reaction Methods 0.000 claims description 7
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 3
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 claims description 3
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 238000006555 catalytic reaction Methods 0.000 claims description 2
- 229940125904 compound 1 Drugs 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract description 18
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract description 9
- 239000001569 carbon dioxide Substances 0.000 abstract description 5
- 239000002904 solvent Substances 0.000 abstract description 4
- 239000000758 substrate Substances 0.000 description 23
- 239000003054 catalyst Substances 0.000 description 16
- UUJCYIMTWZWQFW-UHFFFAOYSA-N 1-ethyl-2-phenylaziridine Chemical compound CCN1CC1C1=CC=CC=C1 UUJCYIMTWZWQFW-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- FSJSYDFBTIVUFD-XHTSQIMGSA-N (e)-4-hydroxypent-3-en-2-one;oxovanadium Chemical compound [V]=O.C\C(O)=C/C(C)=O.C\C(O)=C/C(C)=O FSJSYDFBTIVUFD-XHTSQIMGSA-N 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- MFWFDRBPQDXFRC-LNTINUHCSA-N (z)-4-hydroxypent-3-en-2-one;vanadium Chemical compound [V].C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O.C\C(O)=C\C(C)=O MFWFDRBPQDXFRC-LNTINUHCSA-N 0.000 description 3
- SZOKIVORZWCWIB-UHFFFAOYSA-N 1-ethyl-2-(4-methylphenyl)aziridine Chemical compound CCN1CC1c1ccc(C)cc1 SZOKIVORZWCWIB-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 208000012839 conversion disease Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- MENDNJGGIBBTQZ-UHFFFAOYSA-N 1-cyclohexyl-2-phenylaziridine Chemical compound C1C(C=2C=CC=CC=2)N1C1CCCCC1 MENDNJGGIBBTQZ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- RGVBVVVFSXWUIM-UHFFFAOYSA-M bromo(dimethyl)sulfanium;bromide Chemical compound [Br-].C[S+](C)Br RGVBVVVFSXWUIM-UHFFFAOYSA-M 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000002485 combustion reaction Methods 0.000 description 2
- 150000004696 coordination complex Chemical class 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- WZZMHOBVLAEJOD-UHFFFAOYSA-N methylsulfanylmethane;hydrobromide Chemical compound [Br-].C[SH+]C WZZMHOBVLAEJOD-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- GCSBYWTVHSKTNC-UHFFFAOYSA-N 1,3-oxazolidin-5-one Chemical compound O=C1CNCO1 GCSBYWTVHSKTNC-UHFFFAOYSA-N 0.000 description 1
- WDZMBYZWOSXOIZ-UHFFFAOYSA-N 1-butyl-2-phenylaziridine Chemical compound CCCCN1CC1C1=CC=CC=C1 WDZMBYZWOSXOIZ-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- FLIPVKQYNWMJSJ-UHFFFAOYSA-N 2-phenyl-1-propylaziridine Chemical compound CCCN1CC1C1=CC=CC=C1 FLIPVKQYNWMJSJ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000002803 fossil fuel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2204—Organic complexes the ligands containing oxygen or sulfur as complexing atoms
- B01J31/2208—Oxygen, e.g. acetylacetonates
- B01J31/2213—At least two complexing oxygen atoms present in an at least bidentate or bridging ligand
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/30—Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
- B01J2231/34—Other additions, e.g. Monsanto-type carbonylations, addition to 1,2-C=X or 1,2-C-X triplebonds, additions to 1,4-C=C-C=X or 1,4-C=-C-X triple bonds with X, e.g. O, S, NH/N
- B01J2231/341—1,2-additions, e.g. aldol or Knoevenagel condensations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/20—Complexes comprising metals of Group II (IIA or IIB) as the central metal
- B01J2531/26—Zinc
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/20—Complexes comprising metals of Group II (IIA or IIB) as the central metal
- B01J2531/27—Cadmium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/30—Complexes comprising metals of Group III (IIIA or IIIB) as the central metal
- B01J2531/37—Lanthanum
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/50—Complexes comprising metals of Group V (VA or VB) as the central metal
- B01J2531/56—Vanadium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/60—Complexes comprising metals of Group VI (VIA or VIB) as the central metal
- B01J2531/64—Molybdenum
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
本发明公开了一种常压催化CO2合成恶唑烷酮类化合物的方法,所述方法为:以氮丙啶类化合物原料,MOx(acac)n/卤化季铵盐为催化体系,常压下在CO2气氛中搅拌反应得到恶唑烷酮类化合物,恶唑烷酮类化合物包括5‑取代恶唑烷酮和4‑取代恶唑烷酮。本发明提供的方法能在常压下高效催化二氧化碳与氮丙啶类化合物反应制备恶唑烷酮类化合物,该方法具有操作简便、无需额外溶剂和反应条件温和的优点。
The invention discloses a method for synthesizing oxazolidinone compounds by catalyzing CO2 under normal pressure. The method is as follows: using aziridine compounds as raw materials, MO x (acac) n /halogenated quaternary ammonium salt as the catalytic system, usually The reaction is stirred under pressure in a CO 2 atmosphere to obtain oxazolidinone compounds, which include 5-substituted oxazolidinones and 4-substituted oxazolidinones. The method provided by the invention can efficiently catalyze the reaction of carbon dioxide and aziridine compounds to prepare oxazolidinone compounds under normal pressure. The method has the advantages of simple operation, no need for additional solvents, and mild reaction conditions.
Description
技术领域Technical field
本发明属于恶唑烷酮类化合物的合成技术领域,特别涉及一种常压催化CO2合成恶唑烷酮类化合物的方法。The invention belongs to the technical field of synthesis of oxazolidinone compounds, and particularly relates to a method for synthesizing oxazolidinone compounds using atmospheric pressure catalytic CO 2 .
背景技术Background technique
化石燃料的燃烧在过去的一百多年里一直是几乎所有工业与民生的热能与动力基础,其燃烧所产生的二氧化碳(CO2)均被排放到大气中,对对全球变暖和人类健康造成了严重影响。对于CO2问题,在有机转化中将其作为一种可再生的廉价原料具有特殊的吸引力,因为它可减少新化学品的碳足迹和我们对化石资源的依赖[Energ.Environ.Sci.2020,13,1561-1567;Acs Catal.2019,9,7937-7956;Adv.Syn.Catal.2019,361,223-246.]。The combustion of fossil fuels has been the heat and power basis for almost all industries and people's livelihoods for more than a hundred years. The carbon dioxide (CO 2 ) produced by its combustion is emitted into the atmosphere, causing serious consequences for global warming and human health. had a serious impact. Regarding the CO2 problem, its use as a renewable, cheap feedstock in organic conversion has particular appeal as it reduces the carbon footprint of new chemicals and our dependence on fossil resources [Energ.Environ.Sci.2020 ,13,1561-1567;Acs Catal.2019,9,7937-7956;Adv.Syn.Catal.2019,361,223-246.].
恶唑烷酮是一类在五元环中同时含有氧和氮的有机杂环结构,是多种恶唑烷酮类抗菌药的核心结构[Molecules 2021,26,4280],同时也是重要的有机合成中间体和助剂[Acc.Chem.Res.2021,54,2969-2990;J.Am.Chem.Soc.1981,103,2127-2129],用途十分广泛,人们对该类化合物的合成越来越重视。以CO2为酯基源与氮丙啶反应合成恶唑烷酮[RSCAdvances 2019,9,19465-19482;Chem.Eng.Sci.2021,232,116380;J.Org.Chem.2014,79,9771-9777],与使用高毒性试剂如光气的传统路线[J.Am.Chem.Soc.2003,125,2489-2506.]相比,该方法不仅利用了CO2,还具备原子经济性为100%的绿色化学特征。然而,受CO2的高度稳定性和催化剂活性限制,该反应通常需要高压、和/或较高的反应温度、或催化剂合成复杂、成本较高,尤其是在常压下实现该CO2高效转化的催化体系研究很少。亟须开发能够降低二氧化碳活化成本的高效低能耗催化体系。Oxazolidinones are a type of organic heterocyclic structure containing both oxygen and nitrogen in a five-membered ring. They are the core structure of a variety of oxazolidinone antibacterial drugs [Molecules 2021, 26, 4280] and are also important organic compounds. Synthetic intermediates and auxiliaries [Acc.Chem.Res.2021,54,2969-2990; J.Am.Chem.Soc.1981,103,2127-2129] are widely used, and people are more and more interested in the synthesis of this type of compounds. Come pay more and more attention to it. Oxazolidinones are synthesized by reacting CO 2 as the ester group source with aziridine [RSCAdvances 2019, 9, 19465-19482; Chem.Eng.Sci.2021, 232, 116380; J.Org.Chem.2014, 79, 9771 -9777], compared with the traditional route using highly toxic reagents such as phosgene [J.Am.Chem.Soc.2003,125,2489-2506.], this method not only utilizes CO 2 but also has an atom economy of 100% Green Chemistry Characteristics. However, limited by the high stability and catalyst activity of CO 2 , this reaction usually requires high pressure and/or higher reaction temperature, or the catalyst synthesis is complex and costly, especially to achieve efficient conversion of CO 2 under normal pressure. There are few studies on catalytic systems. There is an urgent need to develop efficient and low-energy catalytic systems that can reduce the cost of carbon dioxide activation.
发明内容Contents of the invention
本发明的目的在于提供一种常压催化CO2合成恶唑烷酮类化合物的方法,能在常压下高效催化二氧化碳与氮丙啶类化合物反应制备恶唑烷酮类化合物,该方法具有操作简便、无需额外溶剂和反应条件温和的优点。The object of the present invention is to provide a method for catalyzing CO 2 to synthesize oxazolidinone compounds under normal pressure, which can efficiently catalyze the reaction of carbon dioxide and aziridine compounds to prepare oxazolidinone compounds under normal pressure. The method has the operation It has the advantages of simplicity, no need for additional solvents, and mild reaction conditions.
本发明提供如下技术方案:The present invention provides the following technical solutions:
一种常压催化CO2合成恶唑烷酮类化合物的方法,所述方法为:以氮丙啶类化合物1原料,MOx(acac)n/卤化季铵盐为催化体系,常压下在CO2气氛中搅拌反应得到恶唑烷酮类化合物,恶唑烷酮类化合物包括5-取代恶唑烷酮2和4-取代恶唑烷酮3,合成过程的反应方程式如下:A method for synthesizing oxazolidinone compounds by catalyzing CO2 under normal pressure. The method is as follows: using aziridine compound 1 as raw material, MO x (acac) n / halogenated quaternary ammonium salt as the catalytic system, under normal pressure The oxazolidinone compounds are obtained by stirring reaction in CO2 atmosphere. The oxazolidinone compounds include 5-substituted oxazolidinone 2 and 4-substituted oxazolidinone 3. The reaction equation of the synthesis process is as follows:
其中,R1为直链烷基、环烷基或苄基,R2为芳基;MOx(acac)n为乙酰丙酮金属配合物或乙酰丙酮金属配合物氧化物,x的取值范围为0-2,n的取值范围为2-3。Among them, R 1 is a linear alkyl group, cycloalkyl group or benzyl group, R 2 is an aryl group; MO x (acac) n is an acetylacetone metal complex or an acetylacetone metal complex oxide, and the value range of x is 0-2, the value range of n is 2-3.
本发明的反应机理在于:金属配合物与四丁基卤化物通过协同作用催化反应,金属配合物金属中心通过与氮杂环丙烷中的N原子的形成配位作用活化底物。The reaction mechanism of the present invention is that the metal complex and tetrabutyl halide catalyze the reaction through synergistic interaction, and the metal center of the metal complex activates the substrate through coordination with the N atoms in the aziridine.
所述反应的温度为40-80℃,反应的时间为8-24h。当反应温度低于40℃时,反应转化率较低;当反应温度大于80℃时,转化率提升不太明显,因此将反应的温度控制在此范围,在保证反应转化率的同时具有较好的经济效应。当反应时间小于8h时,反应转化率较低;当反应时间大于24h,底物基本转化完全,因此将反应的时间控制在此范围。The temperature of the reaction is 40-80°C, and the reaction time is 8-24h. When the reaction temperature is lower than 40°C, the reaction conversion rate is low; when the reaction temperature is greater than 80°C, the conversion rate is not significantly improved. Therefore, controlling the reaction temperature within this range can ensure the reaction conversion rate while having better performance. economic effects. When the reaction time is less than 8 hours, the reaction conversion rate is low; when the reaction time is greater than 24 hours, the substrate is basically completely converted, so the reaction time is controlled within this range.
所述催化体系中的主催化剂MOx(acac)n中MOx n+为V3+、VO2+、La3+、MoO2 2+、Co2+、Fe2+、Fe3+或Ni2+。In the main catalyst MO x (acac) n in the catalytic system, MO x n+ is V 3+ , VO 2+ , La 3+ , MoO 2 2+ , Co 2+ , Fe 2+ , Fe 3+ or Ni 2 + .
优选的,所述催化体系中MOx(acac)n中MOx n+为V3+、VO2+或La3+、MoO2 2+。当MOx n+为V3+、VO2+或La3+、MoO2 2+时,作为主催化剂,具有更强的催化活性,底物的转化率、产率和产物5-噁唑烷酮的区域选择相对更高。Preferably, MO x n + in MO x (acac) n in the catalytic system is V 3+ , VO 2+ or La 3+ , MoO 2 2+ . When MO x n+ is V 3+ , VO 2+ or La 3+ , MoO 2 2+ , as the main catalyst, it has stronger catalytic activity, the conversion rate of the substrate, the yield and the product 5-oxazolidinone The regional selection is relatively high.
所述催化体系中的助催化剂卤化季铵盐为四丁基氯化铵(TBAC)、四丁基溴化铵(TBAB)或四丁基碘化铵(TBAI)。The cocatalyst quaternary ammonium halide salt in the catalytic system is tetrabutylammonium chloride (TBAC), tetrabutylammonium bromide (TBAB) or tetrabutylammonium iodide (TBAI).
优选的,所述催化体系中卤化季铵盐为四丁基氯化铵(TBAC)、四丁基溴化铵(TBAB)。TBAC和TBAB作为助催化剂,与上述主催化剂具有更好的协同作用,更利于提高其催化活性与反应的选择性。Preferably, the quaternary ammonium halide salt in the catalytic system is tetrabutylammonium chloride (TBAC) or tetrabutylammonium bromide (TBAB). As cocatalysts, TBAC and TBAB have better synergy with the above-mentioned main catalyst, which is more conducive to improving its catalytic activity and reaction selectivity.
所述氮丙啶类化合物、MOx(acac)n和卤化季铵盐的摩尔比例为100:0.5-5:0.5-5。本发明通过控制三者的摩尔比例,可以使其具有较好的催化活性,可以使底物转化率、恶唑烷酮产率和选择性同时较好。The molar ratio of the aziridine compound, MO x (acac) n and quaternary ammonium halide salt is 100:0.5-5:0.5-5. By controlling the molar ratio of the three, the present invention can make it have better catalytic activity, and can make the substrate conversion rate, oxazolidinone yield and selectivity better at the same time.
优选的,所述氮丙啶类化合物、MOx(acac)n和卤化季铵盐的摩尔比例为100:1-2:1-2。将三者的摩尔比例限定在此范围内,更利于提高底物转化率、恶唑烷酮产率和选择性。Preferably, the molar ratio of the aziridine compound, MO x (acac) n and quaternary ammonium halide salt is 100:1-2:1-2. Limiting the molar ratio of the three to this range is more conducive to improving substrate conversion rate, oxazolidinone yield and selectivity.
优选的,所述MOx(acac)n和卤化季铵盐的摩尔比例为1:1。当两者的摩尔比例为1:1,两者的协同效果最好。Preferably, the molar ratio of MO x (acac) n and quaternary ammonium halide salt is 1:1. When the molar ratio of the two is 1:1, the synergistic effect of the two is best.
优选的,所述R1为乙基、丙基、丁基或环己基,R2为苯基或对甲基苯基。Preferably, R 1 is ethyl, propyl, butyl or cyclohexyl, and R 2 is phenyl or p-methylphenyl.
与现有技术相比,本发明具有以下优异效果:Compared with the existing technology, the present invention has the following excellent effects:
(1)本发明提供的方法通过金属配合物与四丁基卤化物的协同作用催化反应,能够有效催化氮丙啶类化合物高效转化为恶唑烷酮类化合物;(1) The method provided by the invention can effectively catalyze the efficient conversion of aziridine compounds into oxazolidinone compounds through the synergistic catalytic reaction of metal complexes and tetrabutyl halides;
(2)本发明提供的方法中的催化体系具有良好的底物适用性,能有效催化多种底物高效转化;(2) The catalytic system in the method provided by the invention has good substrate applicability and can effectively catalyze the efficient conversion of a variety of substrates;
(3)本发明提供的方法能在常压下高效催化二氧化碳与氮丙啶类化合物反应制备恶唑烷酮类化合物,具有操作简便、无需额外溶剂和反应条件温和的优点。(3) The method provided by the invention can efficiently catalyze the reaction of carbon dioxide and aziridine compounds to prepare oxazolidinone compounds under normal pressure, and has the advantages of simple operation, no need for additional solvents, and mild reaction conditions.
附图说明Description of drawings
图1为1-乙基-2-苯基-氮杂环丙烷的核磁共振氢谱图;Figure 1 is the hydrogen nuclear magnetic resonance spectrum of 1-ethyl-2-phenyl-aziridine;
图2为实施例1中制备的反应混合物中途采样的气相色谱图(图中各峰对应的物质由气相色谱-质谱联用技术确定);Figure 2 is a gas chromatogram sampled midway through the reaction mixture prepared in Example 1 (the substances corresponding to each peak in the figure were determined by gas chromatography-mass spectrometry technology);
图3为实施例1中制备的反应混合物中途采样的核磁共振氢谱图。Figure 3 is a proton nuclear magnetic resonance spectrum sampled midway of the reaction mixture prepared in Example 1.
具体实施方式Detailed ways
以下通过实施例对本发明的上述内容做进一步详细说明,但不应该将此理解为本发明上述主题范围仅限于以下的实施例,凡基于上述内容实现的技术均属于本发明的范围。The above contents of the present invention will be further described in detail below through examples. However, this should not be understood to mean that the scope of the above subject matter of the present invention is limited to the following examples. All technologies implemented based on the above contents belong to the scope of the present invention.
实施例中采用的氮杂环丙烷类化合物为自主合成,其他化学试剂均由商业购买未经处理直接使用,厂家为阿拉丁试剂有限公司和九鼎化学等。The aziridine compounds used in the examples were synthesized independently, and other chemical reagents were purchased commercially and used directly without treatment. The manufacturers are Aladdin Reagent Co., Ltd. and Jiuding Chemical.
以甲硫醚和液溴、苯乙烯为原料,在冰水浴的条件下合成中间产物(2-溴-1-苯乙基)二甲基溴化硫(BPDMS);再把BPDMS和乙胺反应最终合成氮杂环丙烷目标产物。Using methyl sulfide, liquid bromine, and styrene as raw materials, the intermediate product (2-bromo-1-phenylethyl) dimethyl sulfide bromide (BPDMS) is synthesized under ice-water bath conditions; then react BPDMS with ethylamine The target product of aziridine is finally synthesized.
反应方程式为:The reaction equation is:
以1-乙基-2-苯基-氮杂环丙烷的合成为例,具体过程如下:Taking the synthesis of 1-ethyl-2-phenyl-aziridine as an example, the specific process is as follows:
反应在100mL圆底烧瓶中进行,将Br2(16.0g,0.1mol)溶于20mL CH3CN中,并在冰水浴中,将该溶液逐滴滴入20mL二甲硫醚(6.2g,0.1mol)-CH3CN溶液中,30min内滴完,生成浅橙色的沉淀物溴化二甲基溴化硫(BDMS,在初步实验中,该浅橙色的固体被分离出来,并通过1H NMR和13C NMR进行了表征,证实其为BDMS)。在冰水浴中继续搅拌30分钟后,加入苯乙烯(11.4g,0.11mol),橙色沉淀消失,片刻后白色沉淀开始形成。在冰水浴中继续搅拌30分钟后,停止反应,过滤,分别用CH3CN和乙醚洗涤滤饼后,真空过夜干燥,得到13.3g(产率,40%)白色粉末BPMDS。The reaction was carried out in a 100mL round-bottomed flask, Br 2 (16.0g, 0.1mol) was dissolved in 20mL CH 3 CN, and in an ice water bath, the solution was added dropwise to 20mL dimethyl sulfide (6.2g, 0.1 mol)-CH 3 CN solution, the dripping was completed within 30 minutes, and a light orange precipitate, dimethyl sulfide bromide (BDMS), was generated. In the preliminary experiment, the light orange solid was separated and analyzed by 1 H NMR It was characterized by 13C NMR and confirmed to be BDMS). After continuing to stir in the ice-water bath for 30 minutes, styrene (11.4g, 0.11mol) was added, the orange precipitate disappeared, and a white precipitate began to form after a while. After continuing to stir in an ice-water bath for 30 minutes, the reaction was stopped, filtered, and the filter cake was washed with CH 3 CN and diethyl ether respectively, and then dried under vacuum overnight to obtain 13.3 g (yield, 40%) of white powder BPMDS.
将BPMDS(3.26g,10mmol)在室温下(~27℃)溶于20mL H2O中,再将20mL乙胺(40mmol)水溶液滴入上述溶液中,搅拌过夜。将混合物倒入40ml饱和盐水中,用乙醚(3*30mL)萃取,萃取液用MgSO4干燥后,过滤取滤液,在减压下除去溶剂,得到无色液体1.41g(产率,96%)。取样采用核磁共振(如图1所示)对产物进行分析,产物即为目标物1-乙基-2-苯基-氮杂环丙烷。BPMDS (3.26g, 10mmol) was dissolved in 20mL H 2 O at room temperature (~27°C), and then 20mL of ethylamine (40mmol) aqueous solution was dropped into the above solution and stirred overnight. Pour the mixture into 40 ml saturated brine, extract with diethyl ether (3*30 mL), dry the extract with MgSO 4 , filter the filtrate, and remove the solvent under reduced pressure to obtain 1.41 g of colorless liquid (yield, 96%) . The product was sampled and analyzed by nuclear magnetic resonance (as shown in Figure 1). The product was the target 1-ethyl-2-phenyl-aziridine.
使用同样的方法还合成了1-丙基-2-苯基-氮杂环丙烷、1-丁基基-2-苯基-氮杂环丙烷、1-环己基-2-苯基-氮杂环丙烷、1-乙基-2-对甲苯基-氮杂环丙烷等反应底物。Using the same method, 1-propyl-2-phenyl-aziridine, 1-butyl-2-phenyl-aziridine, 1-cyclohexyl-2-phenyl-azepine were also synthesized. Reaction substrates such as cyclopropane and 1-ethyl-2-p-tolyl-aziridine.
实施例1Example 1
在5ml玻璃反应瓶中加入1-乙基-2-苯基-氮杂环丙烷(1a)(0.294g,2mmol)、基于1a的2mol%V(acac)3(4*10-3mmol)和基于1a的2mol%TBAC(4*10-3mmol)。用装有CO2的气球(1atm压力)将体系内的气体氛围置换3遍后,将反应瓶置于40℃的金属加热模块中,磁力搅拌(约350-400rpm)反应24h。用气相色谱-质谱联用、核磁氢谱等手段确定反应混合物成分后,用气相色谱分析产物组成,1a的转化率为98%,恶唑烷酮产率为96%,其中2a:3a=92:8。其气相色谱图如图2所示,图中各峰对应的物质由气相色谱-质谱联用技术确定;其核磁共振氢谱图如图3所示。In a 5 ml glass reaction bottle, add 1-ethyl-2-phenyl-aziridine (1a) (0.294g, 2mmol), 2mol% V(acac) 3 (4*10 -3 mmol) based on 1a and 2 mol% TBAC based on 1a (4*10 -3 mmol). After replacing the gas atmosphere in the system 3 times with a balloon filled with CO 2 (1 atm pressure), place the reaction bottle in a metal heating module at 40°C and react with magnetic stirring (about 350-400 rpm) for 24 hours. After determining the components of the reaction mixture using gas chromatography-mass spectrometry, hydrogen nuclear magnetic spectroscopy, etc., the product composition was analyzed using gas chromatography. The conversion rate of 1a was 98%, and the yield of oxazolidinone was 96%, of which 2a:3a=92 :8. The gas chromatogram is shown in Figure 2. The substances corresponding to each peak in the figure are determined by gas chromatography-mass spectrometry technology; the hydrogen nuclear magnetic resonance spectrum is shown in Figure 3.
实施例2Example 2
如实施例1,以1a为底物,催化剂采用基于1a的2mol%VO(acac)2(4*10-3mmol)和基于1a的2mol%TBAC(4*10-3mmol),反应在1atmCO2压力、40℃下反应了24h。得到1a的转化率为97%,恶唑烷酮产率为93%,其中2a:3a=92:8。As in Example 1, 1a is used as the substrate, the catalyst uses 2mol% VO(acac) 2 (4*10 -3 mmol) based on 1a and 2mol% TBAC (4*10 -3 mmol) based on 1a, and the reaction is carried out at 1atmCO 2 pressure and 40°C for 24 hours. The conversion rate of 1a was 97%, and the oxazolidinone yield was 93%, where 2a:3a=92:8.
实施例3Example 3
如实施例1,以1a为底物,催化剂采用基于1a的2mol%MO2(acac)2(4*10-3mmol)和基于1a的2mol%TBAC(4*10-3mmol),反应在1atmCO2压力、40℃下反应了24h。得到1a的转化率为99%,恶唑烷酮产率为96%,其中2a:3a=91:9。As in Example 1, 1a is used as the substrate, the catalyst is 2mol% MO 2 (acac) 2 (4*10 -3 mmol) based on 1a and 2mol% TBAC (4*10 -3 mmol) based on 1a, and the reaction is The reaction was carried out for 24 hours under 1 atm CO 2 pressure and 40°C. The conversion rate of 1a was 99%, and the oxazolidinone yield was 96%, where 2a:3a=91:9.
实施例4Example 4
如实施例1,以1a为底物,催化剂采用基于1a的2mol%La(acac)3(4*10-3mmol)和基于1a的2mol%TBAC(4*10-3mmol),反应在1atmCO2压力、40℃下反应了24h。得到1a的转化率为91%,恶唑烷酮产率为88%,其中2a:3a=92:8。As in Example 1, 1a is used as the substrate, the catalyst is 2mol% La(acac) 3 (4*10 -3 mmol) based on 1a and 2mol% TBAC (4*10 -3 mmol) based on 1a, and the reaction is carried out at 1atmCO 2 pressure and 40°C for 24 hours. The conversion rate of 1a was 91%, and the oxazolidinone yield was 88%, where 2a:3a=92:8.
实施例5-8Examples 5-8
如实施例1,以1a为底物,实施例5-8分别以不同金属中心的乙酰丙酮金属配合物为主催化剂(V(acac)3、VO(acac)2、MoO2(acac)2、La(acac)3),四丁基溴化铵(TBAB)为助催化剂,三者的比例为100:2:2,反应在1atm CO2压力、40℃下反应了24h。As in Example 1, 1a is used as the substrate, and Examples 5-8 use acetylacetone metal complexes with different metal centers as the main catalysts (V(acac) 3 , VO(acac) 2 , MoO 2 (acac) 2 , La(acac) 3 ) and tetrabutylammonium bromide (TBAB) were used as cocatalysts. The ratio of the three was 100:2:2. The reaction was carried out for 24 hours under 1atm CO 2 pressure and 40°C.
对比例1-3Comparative Example 1-3
如实施例5-8,对比例1不添加主催化剂;对比例2-3添加Zn(acac)2、Cd(acac)2作为主催化剂。As in Example 5-8, Comparative Example 1 does not add a main catalyst; Comparative Example 2-3 adds Zn(acac) 2 and Cd(acac) 2 as main catalysts.
实施例5-8以及对比例1-3合成恶唑烷酮的底物转化率、产率和区域选择性如表1所示。在实施例5-8中,MOx(acac)n-TBAB的组合也表现出很好的催化活性,底物的转化率为88%~95%,恶唑烷酮的产率为74~86%,两种异构体的区域选择性为94:6~98:2(表1,编号5-8)。而对比例1-3中,不加入乙酰丙酮金属配合物,仅加入助催化剂TBAB,底物转化率仅为11%;;当使用Zn(acac)2、Cd(acac)2时,底物的转化率为0(表1,编号9-11),说明它们不仅不能促进反应,还阻止了反应的进行。The substrate conversion rate, yield and regioselectivity of the oxazolidinones synthesized in Examples 5-8 and Comparative Examples 1-3 are shown in Table 1. In Examples 5-8, the combination of MO x (acac) n -TBAB also showed good catalytic activity, with a substrate conversion rate of 88% to 95% and an oxazolidinone yield of 74 to 86 %, the regioselectivity of the two isomers is 94:6~98:2 (Table 1, No. 5-8). In Comparative Examples 1-3, no acetylacetone metal complex was added, only cocatalyst TBAB was added, and the substrate conversion rate was only 11%; when Zn(acac) 2 and Cd(acac) 2 were used, the substrate conversion rate was The conversion rate is 0 (Table 1, No. 9-11), indicating that they not only fail to promote the reaction, but also prevent the reaction from proceeding.
表1实施例1-8以及对比例1-3合成恶唑烷酮的底物转化率、产率和区域选择性Table 1 Substrate conversion rate, yield and regioselectivity for the synthesis of oxazolidinones in Examples 1-8 and Comparative Examples 1-3
a反应条件:底物1-乙基-2苯基-氮丙啶(2mmol),MOx(acac)n(0.04mmol,2mol%),TBAX(0.04mmol,2mol%),1atm of CO2,40℃,24h.aReaction conditions: substrate 1-ethyl-2phenyl-aziridine (2mmol), MO x (acac) n (0.04mmol, 2mol%), TBAX (0.04mmol, 2mol%), 1atm of CO 2 , 40℃,24h.
b由气相色谱测定.b is determined by gas chromatography.
c5-取代恶唑烷酮与4-取代恶唑烷酮的比例The ratio of c5-substituted oxazolidinones to 4-substituted oxazolidinones
实施例9Example 9
如实施例1,以1a为底物,催化剂采用基于1a的1mol%V(acac)3(4*10-3mmol)和基于1a的1mol%TBAC(4*10-3mmol),反应在1atmCO2压力、80℃下反应了8h。得到1a的转化率为96%,恶唑烷酮产率为93%,其中2a:3a=90:10。As in Example 1, 1a is used as the substrate, the catalyst is 1mol% V(acac) 3 (4*10 -3 mmol) based on 1a and 1mol% TBAC (4*10 -3 mmol) based on 1a, and the reaction is carried out at 1atmCO 2 pressure and 80°C for 8 hours. The conversion rate of 1a was 96%, and the oxazolidinone yield was 93%, where 2a:3a=90:10.
实施例10Example 10
如实施例9,以1a为底物,催化剂采用基于1a的1mol%VO(acac)2(4*10-3mmol)和基于1a的1mol%TBAC(4*10-3mmol),反应在1atmCO2压力、80℃下反应了8h。得到1a的转化率为99%,恶唑烷酮产率为98%,其中2a:3a=91:9。As in Example 9, 1a is used as the substrate, the catalyst is 1mol% VO(acac) 2 (4*10 -3 mmol) based on 1a and 1mol% TBAC (4*10 -3 mmol) based on 1a, and the reaction is carried out at 1atmCO 2 pressure and 80°C for 8 hours. The conversion rate of 1a was 99%, and the oxazolidinone yield was 98%, where 2a:3a=91:9.
实施例11Example 11
如实施例9,以1a为底物,催化剂采用基于1a的1mol%MO2(acac)2(4*10-3mmol)和基于1a的1mol%TBAC(4*10-3mmol),反应在1atmCO2压力、80℃下反应了8h。得到1a的转化率为95%,恶唑烷酮产率为90%,其中2a:3a=91:9。As in Example 9, 1a is used as the substrate, the catalyst is 1mol% MO 2 (acac) 2 (4*10 -3 mmol) based on 1a and 1mol% TBAC (4*10 -3 mmol) based on 1a, and the reaction is The reaction was carried out for 8 hours under 1 atm CO 2 pressure and 80°C. The conversion rate of 1a was 95%, and the oxazolidinone yield was 90%, where 2a:3a=91:9.
实施例12Example 12
如实施例1,以1-环己基-2-苯基氮丙啶(1b)作为底物,催化剂采用基于1b的1mol%VO(acac)2(2*10-3mmol)和基于1b的1mol%TBAC(2*10-3mmol),反应在1atmCO2压力、40℃下反应了24h。1b的转化率为96%,恶唑烷酮产率为95%,其中2b:3b=100:0。As in Example 1, 1-cyclohexyl-2-phenylaziridine (1b) is used as the substrate, and the catalyst uses 1 mol% VO(acac) 2 (2*10 -3 mmol) based on 1b and 1 mol based on 1b. %TBAC (2*10 -3 mmol), the reaction was carried out at 1atmCO 2 pressure and 40°C for 24h. The conversion rate of 1b was 96%, and the oxazolidinone yield was 95%, where 2b:3b=100:0.
实施例13Example 13
如实施例1,以1-乙基-2-对甲基苯基氮丙啶(1c)作为底物,催化剂采用基于1c的1mol%VO(acac)2(2*10-3mmol)和基于1c的1mol%TBAC(2*10-3mmol),反应在1atmCO2压力、40℃下反应了24h。1c的转化率为95%,恶唑烷酮产率为94%,其中2c:3c=97:3。As in Example 1, 1-ethyl-2-p-methylphenylaziridine (1c) is used as the substrate, and the catalyst uses 1 mol% VO(acac) 2 (2*10 -3 mmol) based on 1c and based on 1c. 1c of 1mol% TBAC (2*10 -3 mmol), the reaction was carried out at 1atmCO2 pressure and 40°C for 24h. The conversion rate of 1c was 95%, and the oxazolidinone yield was 94%, where 2c:3c=97:3.
以上所述仅为本发明的实施例而已,并不用于限制本发明。对于本领域技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原理之内所作的任何修改、等同替换、改进等,均应包含在本发明的权利要求范围之内。The above descriptions are only examples of the present invention and are not intended to limit the present invention. Various modifications and variations will occur to the present invention to those skilled in the art. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention shall be included in the scope of the claims of the present invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310964404.1A CN116987043A (en) | 2023-08-02 | 2023-08-02 | Atmospheric catalytic CO 2 Method for synthesizing oxazolidinone compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310964404.1A CN116987043A (en) | 2023-08-02 | 2023-08-02 | Atmospheric catalytic CO 2 Method for synthesizing oxazolidinone compound |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116987043A true CN116987043A (en) | 2023-11-03 |
Family
ID=88522842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310964404.1A Pending CN116987043A (en) | 2023-08-02 | 2023-08-02 | Atmospheric catalytic CO 2 Method for synthesizing oxazolidinone compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116987043A (en) |
-
2023
- 2023-08-02 CN CN202310964404.1A patent/CN116987043A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110105321A (en) | A kind of method of eutectic ionic liquid catalysis carbon dioxide synthesizing annular carbonate | |
CN109970700A (en) | A kind of quaternary phosphonium type deep eutectic ionic liquid catalyzes the method for coupling carbon dioxide and epoxide to prepare cyclic carbonate | |
CN106925349A (en) | A kind of solid supported type metal porphyrin catalyst and its application in terms of maleic acid is prepared | |
CN107011145A (en) | A kind of method that utilization visible light catalytic prepares the derovatives of alkene 1,4 of 2 iodine penta 2 | |
CN103232426A (en) | Method for preparing benzopyran derivative by choline chloride functional ion liquid catalysis | |
CN108772102A (en) | Miscellaneous more metal effective catalysts of efficient catalytic carbon dioxide synthesizing cyclic carbonate ester | |
CN105732387A (en) | Novel method for asymmetric alpha-hydroxylation of photo-oxygenation beta-dicarbonyl compound based on C-2' phase transfer catalyst | |
CN111253360A (en) | A kind of preparation method of cyclic carbonate | |
CN114478576A (en) | Synthetic method of spiroheterocyclic compound | |
WO2024001487A1 (en) | Method for synthesizing cyclic carbonate from carbon dioxide and epoxy compound and catalyst thereof | |
CN102863335B (en) | Preparation method of diethyl succinate | |
CN110872254B (en) | Pyrazole salt diionic liquid and method for catalyzing synthesis of cyclic carbonate by utilizing the same | |
CN103467434B (en) | Method for preparing eta-caprolactone by composite catalysis | |
CN114289067B (en) | Binary metal catalyst, preparation method and application thereof | |
CN113651681B (en) | A kind of method for preparing aldehyde/ketone by C-C bond cleavage | |
CN116987043A (en) | Atmospheric catalytic CO 2 Method for synthesizing oxazolidinone compound | |
CN108772088A (en) | One kind being used for CO2The g-C of cycloaddition synthesizing annular carbonate3N4Catalyst and preparation method thereof | |
Ganina et al. | Cu-MOF-catalyzed carboxylation of alkynes and epoxides | |
CN104926782B (en) | The method that isothiuronium salts ionic liquid prepares cyclic carbonate | |
CN102775378B (en) | A kind of solvent-free process for catalytic synthesis of cyclic carbonate | |
Bette et al. | New Chiral 1, 2‐Diamines and Their Use in Zinc‐Catalyzed Asymmetric Hydrosilylation of Acetophenone | |
CN112724018B (en) | A kind of preparation method of dialkyl carbonate | |
CN114874081B (en) | Preparation method of green efficient alpha-functionalized ketone | |
CN111807998B (en) | Chiral ligand and application thereof in catalytic preparation of optically active secondary alcohol | |
CN110372507B (en) | A Novel Method for the Preparation of Chiral α-Hydroxy-β-Dicarbonyl Compounds by Photocatalytic Asymmetric Oxidation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Country or region after: China Address after: 314000 No. 899, guangqiong Road, Nanhu District, Jiaxing City, Zhejiang Province Applicant after: Jiaxing University Address before: No. 899 Guangqiong Road, Nanhu District, Jiaxing City, Zhejiang Province Applicant before: JIAXING University Country or region before: China |